Search

23 Oct 2020: The company builds on the research of co-founder Professor Keith Martin of the Department of Clinical Neurosciences. ... The project began in 2014 when Widdowson came across the research of Professor Martin of the Clinical Neurosciences Group at the

23 Oct 2020: According to new research published this week in the journal Frontiers in Behavioural Neuroscience, the app improves users' concentration and the scientists behind the venture say it could prove to be ... Frontiers in Behavioural Neuroscience; 21 Jan 2019

27 Jul 2020: GlycoVue led by Gita Khalili Moghaddam (Department of Clinical Neurosciences). MaterialsNexus led by Jonathan Bean (Department of Materials Science and Metallurgy). ... REAVIS led by Yuanbo Deng (Department of Engineering). Smart Cochlea led by Iwan

5 Oct 2020: GlycoVue led by Gita Khalili Moghaddam (Department of Clinical Neurosciences). REAVIS led by Yuanbo Deng (Department of Engineering).

23 Oct 2020: The CANTAB series of tests are based on the research of Professor Barbara Sahakian and Professor Trevor Robbins of the University of Cambridge MRC /Wellcome Trust Behavioural and Clinical Neuroscience Institute.

23 Oct 2020: Professor Alastair Compston, Professor of Neurology and Head of the Department of Clinical Neurosciences at the University of Cambridge, said: “I am delighted that the decision from NICE will make Lemtrada ... Campath-1H was identified as a potential

23 Oct 2020: author Professor Magdalena Zernicka-Goetz of The Wellcome Trust/Cancer Research UK Gurdon Institute and the Department of Physiology, Development and Neuroscience at Cambridge University.

23 Oct 2020: Professor Alastair Compston, Professor of Neurology and Head of the Department of Clinical Neurosciences at the University of Cambridge, said: “I am delighted that the decision from NICE will make Lemtrada ... Campath-1H was identified as a potential

23 Oct 2020: Most recently he was Senior Director and Research Project Leader, Clinical Research at Pfizer Neusentis within the Neuroscience and Pain Research Unit.

23 Oct 2020: For Hovorka, various other trials of the artificial pancreas system are also in progress, including in the control of blood sugar in patients in the Neurosciences Critical Care Unit at Cambridge

23 Oct 2020: Quethera was co-founded in 2013 by Dr Peter Widdowson and Professor Keith Martin (Professor and Head of Ophthalmology, Department of Clinical Neurosciences, University of Cambridge).

23 Oct 2020: In 1991, Alastair Compston (Professor of Neurology and Head of the Department of Clinical Neurosciences) began to explore the use of Alemtuzumab as a treatment for the autoimmune disease MS. ... Dr Coles, from the Department of Clinical Neurosciences,

23 Oct 2020: State-of-the-art neuroscience at the University of Cambridge, combined with the innovative approach at Peak, will help bring the games industry to a new level and promote the benefits ... The impact of neuroscience on society: Cognitive enhancement in

23 Oct 2020: Campath-1H was identified as a potential treatment for multiple sclerosis by Professor Alastair Compston, Professor of Neurology and Head of the Department of Clinical Neurosciences, in the late 1980s.

23 Oct 2020: In 1991, Professor Alastair Compston (current Head of the Department of Clinical Neurosciences) began to explore the use of alemtuzumab as a treatment for the autoimmune disease multiple sclerosis.

27 Nov 2020: Campden Instruments contributed to the proliferation of the science by organising touchscreen seminars at the Society for Neuroscience meeting, and supporting a symposium.

23 Oct 2020: of Clinical Neurosciences, who is also a Quethera founder.